Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
Artis, D.R., Lin, J.J., Zhang, C., Wang, W., Mehra, U., Perreault, M., Erbe, D., Krupka, H.I., England, B.P., Arnold, J., Plotnikov, A.N., Marimuthu, A., Nguyen, H., Will, S., Signaevsky, M., Kral, J., Cantwell, J., Settachatgull, C., Yan, D.S., Fong, D., Oh, A., Shi, S., Womack, P., Powell, B., Habets, G., West, B.L., Zhang, K.Y., Milburn, M.V., Vlasuk, G.P., Hirth, K.P., Nolop, K., Bollag, G., Ibrahim, P.N., Tobin, J.F.
Proc.Natl.Acad.Sci.USA
